The development of the announcement of the Covid-19 vaccine which has a high level of effectiveness has succeeded in increasing market expectations while encouraging market players to tend to make risky investments.
According to a statement, the coronavirus vaccine developed by the drug company AstraZeneca and Oxford University showed 70% effectiveness in a trial involving 23,000 individuals. In addition, the effectiveness recorded ranged from 62% to 90% depending on the dose of the vaccine.
The vaccine manufacturer will prepare data submission to authorities worldwide with prior consent. The AstraZeneca vaccine report was released after the US-based Moderna Inc vaccine report announced that their vaccine had a 94.5% more effective effectiveness in preventing the Covid-19 pandemic.
On Sunday, U.S. health officials said the vaccine distribution could be distributed as early as mid-December.
Following this incident, Paul Donova, who is the chief economist at UBS Global Wealth Management stated that expectations for vaccines have increased interest in risky assets.
The US dollar index, which measures the greenback against the major, recorded a decline of 0.39% to the 92.037 exchange rate.
Elsewhere, the euro continued to strengthen at the 1.19 exchange rate against the US dollar. European Union leaders will continue talks on the Covid-19 recovery plan worth 1.8 trillion euros.
